CD1d expression on B-precursor acute lymphoblastic leukemia subsets with poor prognosis. 2005

F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
Human Anatomy Section, Department of Experimental Medicine, University of Genoa, Italy. franco.fais@unige.it

Acute lymphoblastic leukemia (ALL) is the most frequent malignancy of childhood. Although therapeutical advances have been achieved, some ALL subgroups still fare poorly. CD1d is a monomorphic molecule that provides a suitable target for immunotherapy in view of the characterization of a glycolipid, alpha-galactosylceramide (alpha-GalCer), capable of being presented to CD1d-restricted T cells with cytotoxic potential. We investigated CD1d expression in 80 pediatric B-cell precursor (BCP) ALL cases defined according to immunophenotype, cytogenetic features and age at onset. CD1d was detected on ALL cells in 15% of the patients. CD1d+ ALLs were significantly associated with infant leukemia, pro-B phenotype and mixed-lineage leukemia (MLL)/AF4 gene rearrangement. Accordingly, overall survival of patients with CD1d+ ALL was significantly shorter. CD1d+ leukemic blasts were able to present alpha-GalCer via CD1d to cytotoxic CD1d-restricted T cells, which induced apoptosis of ALL cells that was inhibited by mAb to CD1d. CD1d+ blasts loaded with alpha-GalCer elicited cytokine secretion by CD1d-restricted T cells. Analysis of bone marrow (BM) cells derived from normal donors revealed that CD19+/CD1d+ cells were mostly mature B lymphocytes. However, a minority of BCPs expressed CD1d. Thus, expression of CD1d in ALL cases heralds an adverse prognosis but may provide a therapeutic tool.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002450 Cell Communication Any of several ways in which living cells of an organism communicate with one another, whether by direct contact between cells or by means of chemical signals carried by neurotransmitter substances, hormones, and cyclic AMP. Cell Interaction,Cell-to-Cell Interaction,Cell Communications,Cell Interactions,Cell to Cell Interaction,Cell-to-Cell Interactions,Communication, Cell,Communications, Cell,Interaction, Cell,Interaction, Cell-to-Cell,Interactions, Cell,Interactions, Cell-to-Cell
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005699 Galactosylceramides Cerebrosides which contain as their polar head group a galactose moiety bound in glycosidic linkage to the hydroxyl group of ceramide. Their accumulation in tissue, due to a defect in beta-galactosidase, is the cause of galactosylceramide lipidosis or globoid cell leukodystrophy. Galactocerebrosides,Galactosyl Ceramide,Galactosyl Ceramides,Galactosylceramide,Ceramide, Galactosyl,Ceramides, Galactosyl
D006412 Hematopoietic Stem Cells Progenitor cells from which all blood cells derived. They are found primarily in the bone marrow and also in small numbers in the peripheral blood. Colony-Forming Units, Hematopoietic,Progenitor Cells, Hematopoietic,Stem Cells, Hematopoietic,Hematopoietic Progenitor Cells,Cell, Hematopoietic Progenitor,Cell, Hematopoietic Stem,Cells, Hematopoietic Progenitor,Cells, Hematopoietic Stem,Colony Forming Units, Hematopoietic,Colony-Forming Unit, Hematopoietic,Hematopoietic Colony-Forming Unit,Hematopoietic Colony-Forming Units,Hematopoietic Progenitor Cell,Hematopoietic Stem Cell,Progenitor Cell, Hematopoietic,Stem Cell, Hematopoietic,Unit, Hematopoietic Colony-Forming,Units, Hematopoietic Colony-Forming
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
October 2014, Carcinogenesis,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
February 1999, Cancer genetics and cytogenetics,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
July 2012, Pediatric blood & cancer,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
January 1994, Anticancer research,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
March 2014, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
October 2012, Leukemia,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
August 2013, Leukemia research,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
April 2011, Pediatric blood & cancer,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
July 1996, American journal of hematology,
F Fais, and C Tenca, and G Cimino, and V Coletti, and S Zanardi, and D Bagnara, and D Saverino, and D Zarcone, and G De Rossi, and E Ciccone, and C E Grossi
August 2007, Leukemia research,
Copied contents to your clipboard!